FBRX

Forte Biosciences, Inc. - Common Stock (FBRX)

About Forte Biosciences, Inc. - Common Stock (FBRX)

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Details

Daily high

$10.70

Daily low

$10.08

Price at open

$10.19

52 Week High

$28.68

52 Week Low

$4.11

Market cap

124.3M

Dividend yield

0.00%

Volume

27,251

Avg. volume

195,255

P/E ratio

-.74

Forte Biosciences, Inc. - Common Stock News